September 24, 2007
Page 1 of 2 1 2
On October 4-7, 2007, the 14th International Symposium on Drugs Affecting Lipid Metabolism will be held in New York City. Jointly sponsored by Weill Cornell Medical College and the Lorenzini Foundation, the conference will explore current challenges and recent developments in the pharmacological management of dyslipidemia, one of the major risk factors for cardiovascular disease. Dean Antonio M. Gotto Jr., an internationally recognized expert in the field of lipid metabolism and cardiovascular prevention, will be co-chairing the event.
Page 1 of 2 1 2